BRCA1 and breast cancer: In contrast, BRCA1 overexpression in breast cancer cells stimulates ARE-driven transcriptional activity and upregulates phase II antioxidant enzymes, including glutathione S-transferase and glutathione peroxidase, by enhancing the activity of NRF2 110.